Biomaterials.info

powered by FreeFind

US Food and Drug Administration (FDA) - Inactive Ingredients
FDA Inactive Ingredients - Updated May 2006

What is the purpose of the Inactive Ingredients Database?

The Inactive Ingredients Database provides information on inactive ingredients present in FDA-approved drug products. This information can be used by industry as an aid in developing drug products. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar type of product. 		FDA Devices
FDA Inactive Ingredients
FDA Inactive Ingredients
FDA Inactive Ingredients


First Page Previous Page Next Page Last Page
Inactive Ingredient Route / Dosage Form
CROSPOVIDONE ORAL; TABLET, CONTROLLED RELEASE
CROSPOVIDONE ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
CROSPOVIDONE ORAL; TABLET, DISPERSIBLE
CROSPOVIDONE ORAL; TABLET, ENTERIC COATED PARTICLES
CROSPOVIDONE ORAL; TABLET, EXTENDED RELEASE
CROSPOVIDONE ORAL; TABLET, FILM COATED
CROSPOVIDONE ORAL; TABLET, MULTILAYER, EXTENDED RELEASE
CROSPOVIDONE ORAL; TABLET, ORALLY DISINTEGRATING
CROSPOVIDONE ORAL; TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
CROSPOVIDONE ORAL; TABLET, REPEAT ACTION
CROSPOVIDONE ORAL; TABLET, SUSTAINED ACTION
CROSPOVIDONE ORAL; TABLET, SUSTAINED ACTION, COATED
CROSPOVIDONE ORAL; TABLET, SUSTAINED ACTION, FILM COATED
CROSPOVIDONE ORAL-21; TABLET
CROSPOVIDONE SUBLINGUAL; TABLET
CROSPOVIDONE TOPICAL; EMULSION
CROSPOVIDONE TOPICAL; LOTION
CROSPOVIDONE VAGINAL; SUPPOSITORY
CROSPOVIDONE VAGINAL; TABLET
CRYSTAL GUM ORAL; TABLET
CUPRIC SULFATE AURICULAR (OTIC); SOLUTION
CUPRIC SULFATE AURICULAR (OTIC); SUSPENSION
CUPRIC SULFATE, ANHYDROUS AURICULAR (OTIC); SOLUTION, DROPS
CUTINA SUBLINGUAL; TABLET
CYCLAMIC ACID ORAL; SUSPENSION
CYCLOMETHICONE ORAL; POWDER, FOR SOLUTION
CYCLOMETHICONE TOPICAL; CREAM, AUGMENTED
CYCLOMETHICONE TOPICAL; EMULSION, CREAM
CYCLOMETHICONE TOPICAL; LOTION
CYCLOMETHICONE/DIMETHICONE COPOLYOL TOPICAL; GEL
CYSTEINE IM - SC; INJECTION, SUSTAINED ACTION
CYSTEINE INTRAVENOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
CYSTEINE IV(INFUSION); SOLUTION, INJECTION
CYSTEINE HYDROCHLORIDE INTRAVENOUS; INJECTION
CYSTEINE HYDROCHLORIDE INTRAVENOUS; POWDER, FOR INJECTION SOLUTION
CYSTEINE HYDROCHLORIDE IV(INFUSION); INJECTION
CYSTEINE HYDROCHLORIDE IV(INFUSION); POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
CYSTEINE HYDROCHLORIDE ORAL; CAPSULE
CYSTEINE HYDROCHLORIDE ORAL; TABLET, SUSTAINED ACTION, FILM COATED
CYSTEINE HYDROCHLORIDE, ANHYDROUS INTRADISCAL; POWDER, FOR INJECTION SOLUTION
DAUBERT 1-5 PESTR (MATTE) 164Z TRANSDERMAL; FILM, CONTROLLED RELEASE
DC ANTIFOAM AF TRITURATION 1% ON SUCROSE ORAL; POWDER, FOR SOLUTION
DC ANTIFOAM AF TRITURATION 1% ON SUCROSE ORAL; POWDER, FOR SUSPENSION
DEHYDROACETIC ACID TOPICAL; LOTION
DEHYDROACETIC ACID TOPICAL; SHAMPOO
DEHYMULS E TOPICAL; OINTMENT
DENATONIUM BENZOATE TOPICAL; GEL
DENATONIUM BENZOATE TOPICAL; SOLUTION
DENATONIUM BENZOATE TOPICAL; SWAB
DEOXYCHOLIC ACID IV(INFUSION); POWDER, FOR INJECTION SOLUTION
DEXTRAN INTRAVENOUS; LIQUID, CONCENTRATE, INJECTION
DEXTRAN 40 INTRAVENOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
DEXTRATES ORAL; TABLET
DEXTRATES ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
DEXTRATES ORAL; TABLET, SUSTAINED ACTION
DEXTRIN ORAL; TABLET
DEXTRIN ORAL; TABLET, COATED
DEXTRIN ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
DEXTRIN TOPICAL; EMULSION, CREAM
DEXTRIN TOPICAL; LOTION
DEXTRIN TOPICAL; SHAMPOO
DEXTRINS MODIFIED ORAL-28; TABLET
DEXTROSE IM - IV - SC; INJECTION
DEXTROSE IM - IV; INJECTION
DEXTROSE IM - IV; POWDER, FOR INJECTION SOLUTION
DEXTROSE INTERSTITIAL; INJECTION
DEXTROSE INTRACAVITARY; INJECTION
DEXTROSE INTRAMUSCULAR; INJECTION
DEXTROSE INTRAPERITONEAL; INJECTION
DEXTROSE INTRAPLEURAL; INJECTION
DEXTROSE INTRASPINAL; INJECTION
DEXTROSE INTRAVENOUS; INJECTION
DEXTROSE INTRAVENOUS; INJECTION, SOLUTION
DEXTROSE INTRAVENOUS; POWDER, FOR INJECTION SOLUTION
DEXTROSE INTRAVENOUS; SOLUTION, INJECTION
DEXTROSE IV(INFUSION); INJECTION
DEXTROSE IV(INFUSION); POWDER, FOR INJECTION SOLUTION
DEXTROSE IV(INFUSION); SOLUTION, INJECTION
DEXTROSE NASAL; SPRAY
DEXTROSE NASAL; SPRAY, METERED
DEXTROSE ORAL; CONCENTRATE
DEXTROSE ORAL; PASTILLE
DEXTROSE ORAL; POWDER, FOR SOLUTION
DEXTROSE ORAL; SUSPENSION
DEXTROSE ORAL; SYRUP
DEXTROSE ORAL; TABLET
DEXTROSE ORAL; TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
DEXTROSE ORAL; TABLET, SUSTAINED ACTION, COATED
DEXTROSE ORAL; TABLET, UNCOATED, TROCHE
DEXTROSE SPINAL; INJECTION
DEXTROSE SUBLINGUAL; TABLET
DEXTROSE SOLUTION INTRAVENOUS; INJECTION
DEXTROSE SOLUTION IV(INFUSION); POWDER, FOR INJECTION SOLUTION
DEXTROSE SOLUTION ORAL; SYRUP
DEXTROSE, ANHYDROUS IM - IV; INJECTABLE
DEXTROSE, ANHYDROUS IM - IV; POWDER, FOR INJECTION SOLUTION
DEXTROSE, ANHYDROUS IM - SC; INJECTION
DEXTROSE, ANHYDROUS INTRAMUSCULAR; INJECTION
DEXTROSE, ANHYDROUS INTRAVENOUS; INJECTION
DEXTROSE, ANHYDROUS INTRAVENOUS; KIT

First Page Previous Page Next Page Last Page




Last Modified: 29 April 2006
http://www.biomaterials.info
Sitemap
Link | Link | Link | Link | Link | Link | Link | Link